Lgr5tm2.1Npa
Targeted Allele Detail
|
|
| Symbol: |
Lgr5tm2.1Npa |
| Name: |
leucine rich repeat containing G protein coupled receptor 5; targeted mutation 2.1, Novartis Pharma AG |
| MGI ID: |
MGI:6724063 |
| Synonyms: |
Lgr5lox, LGR5tm1Npa |
| Gene: |
Lgr5 Location: Chr10:115286219-115423685 bp, - strand Genetic Position: Chr10, 63.51 cM
|
| Alliance: |
Lgr5tm2.1Npa page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:236636
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A loxP site was inserted upstream of exon 1 and a second loxP site into intron 1. The loxP sites are approximately 1.6 kb apart and flank the start codon-containing first exon. The FRT site flanked neomycin resistance gene cassette that was also inserted, was removed through subsequent flp-mediated recombination.
(J:236636)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Lgr5 Mutation: |
58 strains or lines available
|
|
| Original: |
J:236636 Planas-Paz L, et al., The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat Cell Biol. 2016 May;18(5):467-79 |
| All: |
2 reference(s) |
|